Key result
Recent literature improves understanding of pathogenesis, genetics, ambulatory monitoring, and drug therapy for pediatric hypertension.
Why the study?
There has been a surge of interest in childhood and adolescent hypertension, necessitating a summary of recent advances in pathogenesis, diagnosis, and treatment.
This review provides an update on the understanding of pathogenesis, diagnosis, and treatment of pediatric hypertension as of 2001.
Answers are grounded in this paper and cite their sources.
May refine pediatric hypertension care; leaves open need for contemporary randomized validation.
During the past decade, there has been a surge of interest in childhood and adolescent hypertension. The current review summarizes work published during the past year in the following areas: prenatal and early postnatal causes of hypertension; new information on the genetics of childhood hypertension; the relation of obesity, insulin resistance, and diabetes to hypertension; the use of ambulatory blood pressure monitoring to evaluate childhood hypertension; and advances in drug therapy for children with hypertension. The information obtained during the past year has improved our understanding of the pathogenesis, diagnosis, and treatment of childhood hypertension.
No takes yet. Share an insight, caveat, or question.
Albert P. Rocchini (2002) conducted a review in Childhood and adolescent hypertension. Recent literature has improved the understanding of the pathogenesis, genetics, diagnosis via ambulatory monitoring, and drug therapy for childhood and adolescent hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: